149 related articles for article (PubMed ID: 8562458)
21. Retrospective DNA analyses in cervical dysplasia as related to neoplastic progression or regression.
Nasiell K; Auer G; Nasiell M; Zetterberg A
Anal Quant Cytol; 1979; 1(2):103-6. PubMed ID: 543572
[TBL] [Abstract][Full Text] [Related]
22. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of morphological nuclear parameters and DNA ploidy pattern in precancerous lesions of the uterine cervix.
Kashyap V; Luthra UK
Indian J Pathol Microbiol; 1995 Apr; 38(2):193-7. PubMed ID: 8919109
[TBL] [Abstract][Full Text] [Related]
24. Application of malignancy-associated changes of the cervical epithelium in a hierarchic classification concept.
Haroske G; Bergander S; König R; Meyer W
Anal Cell Pathol; 1990 Apr; 2(3):189-98. PubMed ID: 2275865
[TBL] [Abstract][Full Text] [Related]
25. Some remarks on preinvasive cervical neoplasia--an image analysis study.
Haroske G; Kunze KD; Dimmer V; Meyer W
Arch Geschwulstforsch; 1985; 55(4):245-52. PubMed ID: 4037995
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of prospective malignancy in koilocytic dysplasias of the cervix with DNA cytometry.
Chatelain R; Schunck T; Schindler EM; Schindler AE; Böcking A
J Reprod Med; 1989 Aug; 34(8):505-10. PubMed ID: 2810239
[TBL] [Abstract][Full Text] [Related]
27. Thionine-Feulgen-Congo red staining of cervical smears for the BioPEPR image-analysis system.
Oud PS; Zahniser DJ; Raaijmakers MC; Vooijs PG; Van de Walle RT
Anal Quant Cytol; 1981 Dec; 3(4):289-94. PubMed ID: 6174058
[TBL] [Abstract][Full Text] [Related]
28. An expanded cervical cell classification system validated by automated measurements.
Stern E; Rosenthal DL; McLatchie C; White BS; Castleman KR
Anal Quant Cytol; 1982 Jun; 4(2):110-4. PubMed ID: 7051909
[TBL] [Abstract][Full Text] [Related]
29. Atypical reparative change on cervical/vaginal smears may be associated with dysplasia.
Rimm DL; Gmitro S; Frable WJ
Diagn Cytopathol; 1996 Jun; 14(4):374-9. PubMed ID: 8725141
[TBL] [Abstract][Full Text] [Related]
30. [Assessment of cervical dysplasia with DNA image cytometry].
Böcking A; Motherby H
Pathologe; 1999 Jan; 20(1):25-33. PubMed ID: 10091229
[TBL] [Abstract][Full Text] [Related]
31. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV.
Guillaud M; Adler-Storthz K; Malpica A; Staerkel G; Matisic J; Van Niekirk D; Cox D; Poulin N; Follen M; Macaulay C
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S16-23. PubMed ID: 16188299
[TBL] [Abstract][Full Text] [Related]
32. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
[TBL] [Abstract][Full Text] [Related]
33. Expectation values for low-resolution slit-scan flow prescreening: influence of nuclear shape and DNA density.
Mullaney PF; Mann R; Seger GH; Achatz M
Anal Quant Cytol; 1982 Jun; 4(2):115-22. PubMed ID: 6180664
[TBL] [Abstract][Full Text] [Related]
34. Low grade and ASCUS lesions of the cervix: diagnostic difficulties and reproducibility.
Raab SS
Ann Pathol; 1999; 19(5 Suppl):S87-9. PubMed ID: 10599462
[No Abstract] [Full Text] [Related]
35. [Severe cervical dysplasia: analysis of 42 cases].
Reyna Hinojosa R; Contreras García RI; Cano Vargas CE; González Ramírez R
Ginecol Obstet Mex; 1980 Sep; 48(287):181-9. PubMed ID: 7203098
[No Abstract] [Full Text] [Related]
36. Relation of quantitative features of visually normal intermediate cells in cervical intraepithelial neoplasia I and II smears to progression or nonprogression of the lesion.
Kwikkel HJ; Timmers T; Boon ME; van Rijswijk MM; Stolk JG
Anal Quant Cytol Histol; 1987 Oct; 9(5):405-10. PubMed ID: 3675799
[TBL] [Abstract][Full Text] [Related]
37. A, B & H isoantigens in cervical lesions.
Bisht D; Misra V; Gupta SC; Mehrotra R; Garg S
Indian J Pathol Microbiol; 1998 Jan; 41(1):11-4. PubMed ID: 9581070
[TBL] [Abstract][Full Text] [Related]
38. Prognosis of moderate dysplasia. Predictive value of selected markers in routinely prepared cervical smears.
Rosenthal DL; Philippe A; Hall TL; Harami S; Missirlian N; Suffin SC
Anal Quant Cytol Histol; 1987 May; 9(2):165-8. PubMed ID: 3606775
[TBL] [Abstract][Full Text] [Related]
39. [Follow-up of women with mild cellular changes in the cervix].
Bichel P
Ugeskr Laeger; 2003 May; 165(21):2181. PubMed ID: 12820503
[No Abstract] [Full Text] [Related]
40. Epithelial changes in the cervix: cytological and histological correlation.
Slavin G; Hudson EU
Clin Obstet Gynaecol; 1981 Apr; 8(1):51-64. PubMed ID: 7261526
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
